Recent advances in the developmental origin of neuroblastoma: an overview

被引:0
作者
Mirco Ponzoni
Tiziana Bachetti
Maria Valeria Corrias
Chiara Brignole
Fabio Pastorino
Enzo Calarco
Veronica Bensa
Elena Giusto
Isabella Ceccherini
Patrizia Perri
机构
[1] IRCCS Istituto Giannina Gaslini,Laboratory of Experimental Therapies in Oncology
[2] IRCSS Ospedale Policlinico San Martino,U.O. Proteomica e Spettrometria di Massa
[3] IRCCS Istituto Giannina Gaslini,Laboratory of Genetics and Genomics of Rare Diseases
来源
Journal of Experimental & Clinical Cancer Research | / 41卷
关键词
Neural crest; Neuroblastoma; Adrenergic; Mesenchymal; Core regulatory circuitries; Transcription factors;
D O I
暂无
中图分类号
学科分类号
摘要
Neuroblastoma (NB) is a pediatric tumor that originates from neural crest-derived cells undergoing a defective differentiation due to genomic and epigenetic impairments. Therefore, NB may arise at any final site reached by migrating neural crest cells (NCCs) and their progeny, preferentially in the adrenal medulla or in the para-spinal ganglia.
引用
收藏
相关论文
共 493 条
[1]  
Padovan-Merhar OM(2016)Enrichment of targetable mutations in the relapsed neuroblastoma genome Plos Genet 12 e1006501-2120
[2]  
Raman P(2007)Neuroblastoma Lancet 369 2106-2211
[3]  
Ostrovnaya I(2016)Neuroblastoma Nat Rev Dis Primers 2 16078-69
[4]  
Kalletla K(2010)Recent advances in neuroblastoma N Engl J Med 362 2202-46
[5]  
Rubnitz KR(2005)Oligogenic inheritance in neuroblastoma Cancer Lett 228 65-248
[6]  
Sanford EM(1990)Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas Brain Pathol 1 41-1124
[7]  
Maris JM(1983)Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour Nature 305 245-974
[8]  
Hogarty MD(1984)Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 224 1121-978
[9]  
Bagatell R(2008)Oncogenic mutations of ALK kinase in neuroblastoma Nature 455 971-970
[10]  
Cohn SL(2008)Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 975-935